Related Experiment Video
Updated: Aug 24, 2025

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Determining laboratory parameters in pregnant women with severe COVID-19
Suskhan Djusad1, Rima Irwinda1, Achmad Kemal Harzif1
1Department of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.
Insights
This study identified key laboratory markers to differentiate COVID-19 severity in pregnant women. Aspartate transferase, D-dimer, and albumin levels significantly indicate severe or critical coronavirus disease-19 in pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Clinical Pathology
Background:
- Coronavirus disease (COVID-19) presents a wide clinical spectrum in pregnant women.
- Limited studies focus on laboratory parameters for differentiating COVID-19 severity in this population.
- Identifying specific biomarkers is crucial for timely intervention and management of severe COVID-19 in pregnancy.
Purpose of the Study:
- To determine cut-off values for laboratory parameters that distinguish between asymptomatic/mild/moderate and severe/critical COVID-19 illness in pregnant women.
- To identify specific laboratory markers that are predictive of severe COVID-19 outcomes in pregnancy.
- To aid in risk stratification and clinical decision-making for pregnant patients with COVID-19.
Main Methods:
- A cross-sectional study involving pregnant women diagnosed with COVID-19 between January and August 2021.
- Data collection included demographic characteristics and a comprehensive panel of laboratory parameters from medical records.
- Statistical analysis, including receiver operating characteristic (ROC) curve analysis and multivariate analysis, was performed to identify significant predictors and their cut-off values.
Main Results:
- Out of 159 cases, 130 (81.8%) had asymptomatic/mild/moderate illness and 29 (18.2%) had severe/critical illness.
- Twelve of 28 laboratory parameters showed statistical significance in differentiating severity.
- Multivariate analysis identified aspartate transferase, D-dimer, and albumin as key laboratory parameters significantly impacting COVID-19 severity in pregnant women, with an ROC curve area of 0.834.
Conclusions:
- Several laboratory parameters, including urea, aspartate transferase, alanine transferase, procalcitonin, C-reactive protein, lactate dehydrogenase (LDH), ferritin, D-dimer, random blood glucose, cycle threshold values, albumin, and chloride, differ between severity groups.
- Aspartate transferase, D-dimer, and albumin emerged as the most impactful laboratory parameters for predicting COVID-19 severity in pregnant women.
- These findings provide valuable insights for clinical assessment and management of pregnant individuals with COVID-19.
Objective:
Coronavirus disease causes a wide spectrum of clinical picture in pregnant women. There are still a few studies concerning laboratory parameters to differentiate the severity of coronavirus disease-19 in pregnant patients. This article aims to identify the cut-off on laboratory parameters between pregnant women with asymptomatic/mild/moderate and severe/critical coronavirus disease-19 illness.
Methods:
All coronavirus disease-19 pregnant women coming to Dr. Cipto Mangunkusumo hospital between January and August 2021 were recruited into this cross-sectional study. All data extracted from medical records were classified into demographic characteristics and laboratory parameters. We defined demographic characteristics as age, parity, systolic, and diastolic blood pressure, heart rate, temperature, respiratory rate, and oxygen saturation. Laboratory parameters measured in this study consisted of complete blood count, renal function test including urea, creatinine, liver function test including aspartate transferase, alanine transferase, infection marker test including procalcitonin, C-reactive protein, interleukin-6, cycle threshold values, ferritin, coagulation test including d-dimer, fibrinogen, random blood glucose, albumin, electrolytes. Data analysis was performed using SPSS statistics.
Results:
There were 159 cases assessed in this study consisting of 130 (81.8%) patients with asymptomatic/mild/moderate illness and 29 (18.2%) patients with severe/critical illness of coronavirus disease-19. Of 28 laboratory parameters, 12 of them were significant statistically; thus, it resulted to make a cut-off using receiver operating characteristic curve and show relative risk, and 95% confidence interval. In multivariate analysis that aspartate transferase, D-dimer, and albumin were laboratory parameters impacted to the severity of coronavirus disease-19 in pregnant women. The area under receiver operating characteristic curve was 0.834 (95% CI 0.736-0.932).
Conclusion:
Of all laboratory parameters, urea, aspartate transferase, alanine transferase, procalcitonin, C-reactive protein, lactate dehydrogenase (LDH), ferritin, D-dimer, random blood glucose, cycle threshold values, albumin, and chloride differs between asymptomatic/mild/moderate, and severe/critical illness coronavirus disease-19 in pregnant women; aspartate transferase, D-dimer, and albumin were laboratory parameters impacted the most to the severity of coronavirus disease-19 in pregnant women.
More Related Videos
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
14:40Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015